jean jacques bienaime  professional profile linkedin main content starts below jean jacques bienaimelocationsan francisco bay areaindustrybiotechnologycurrentincyte vital therapies inc biotechnology industry organizationeducationuniversity of pennsylvania  the wharton school connectionsview jean jacques’ full profile its freeyour colleagues classmates and  million other professionals are on linkedinview jean jacques’ full profilejean jacques’ activityjbienaime biomarin pharmaceutical incjean jacques sharedexperienceboard memberincytejanuary  – present  years  monthsboard membervital therapies incaugust  – present  yearsboard memberbiotechnology industry organizationoctober  – present  years  monthswashington dc metro areachairman of the board and chief executive officerbiomarin pharmaceuticalmay  – present  years  monthscontinue to grow the company beyond  billion in revenues become leader in gene therapy in addition to orphan diseasesceobiomarin pharmaceutical incmay  – present  years  monthsvolunteer experience  causescauses jean jacques cares abouteconomic empowermenthuman rightsscience and technologylanguagesfrenchspanishskillsbiotechnologypharmaceutical industrycommercializationlifesciencesoncologymarket accessbiopharmaceuticalscardiologyproduct launchdrug developmentclinical developmenttechnology transferclinical trialsneurologyhows this translationgreat•has errorsthanks for your helpeducationuniversity of pennsylvania  the wharton schoolmaster of business administration mba finance generalmaster of business administration mba finance general – mbaecole superieure de commerce de parisescp diploma econometircs financeescp diploma econometircs finance – view jean jacques’ full profile tosee who you know in commonget introducedcontact jean jacques directlyview jean jacques’ full profileview this profile in another languageenglishgermanchinese simplifiedpeople also viewedrobert baffiexecutive vice president at biomarin pharmaceuticaljulie anne smithpresident and ceo at raptormiguel carrillovp financial planning  analysis at biomarin pharmaceutical incflemming ornskov md mphchief executive officer at shire plcsarah noonberg md phdchief medical officer at prothena corporationgeorge f tidmarshceo la jolla pharmaceuticaljessica cohenmedical director at biomarincharles calderaro iiisenior vice president global manufacturing at biomarin pharmaceutical incanil bagridirector of portfolio strategy and product development at biomarin pharmaceutical incnick leschlyceo at bluebird biopublic profile badgeinclude this linkedin profile on other websitesview profile badgessearch by nameover  million professionals are already on linkedin find who you knowfirst namelast nameexample jeff weinerlinkedin member directoryabcdefghijklmnopqrstuvwxyzmorebrowse members by country jeanjacques bienaime  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in jeanjacques bienaime chief executive officer and chairman of the board at biomarin pharmaceutical inc view full profile are you jeanjacques bienaime claim your profile   sign up for equilar atlas and view jeanjacques bienaimes full profile with equilar atlas you can identify corporate executives in jeanjacques bienaimes network and community follow changes in jeanjacques bienaimes employment and moneyinmotion connect with jeanjacques bienaime through your network of contacts jeanjacques bienaimes executive work history current chief executive officer and chairman of the board biomarin pharmaceutical inc board member incyte corporation board member vital therapies inc past to view jeanjacques bienaimes complete executive work history sign up now age      jeanjacques bienaimes biography the board has nominated mr bienaime for his intimate knowledge of our business and extensive experience in the management of biotechnology organizations business development and sales and marketing of both biotechnology and pharmaceutical products jeanjacques bienaime joined our board in may  the same time that he became our chief executive officer and was named chair of the board in june  from november  to april  mr bienaime served as chairman chief executive officer and president of genencor a biotechnology company focused on industrial bioproducts and targeted cancer biotherapeutics from  to late   read more the board has nominated mr bienaime for his intimate knowledge of our business and extensive experience in the management of biotechnology organizations business development and sales and marketing of both biotechnology and pharmaceutical products jeanjacques bienaime joined our board in may  the same time that he became our chief executive officer and was named chair of the board in june  from november  to april  mr bienaime served as chairman chief executive officer and president of genencor a biotechnology company focused on industrial bioproducts and targeted cancer biotherapeutics from  to late  mr bienaime served as chairman chief executive officer and president of sangstat medical corporation an immunologyfocused biotechnology company becoming president in  and chief executive officer in  from  to  mr bienaime held several senior management positions at rhonepoulenc rorer pharmaceuticals now sanofiaventis culminating in the position of senior vice president of worldwide marketing and business development earlier in his career mr bienaime worked at genentech inc where he was involved in the launch of tissue plasminogen activator tpa for the treatment of heart attacks mr bienaime currently serves on the boards of incyte corporation a public pharmaceutical company and vital therapies inc a public biotechnology company as well as the health section governing board of the biotechnology innovation organization formerly known as the biotechnology industry organization an industry trade association mr bienaime previously served on the board of directors of two public companies during the past five years portola pharmaceuticals inc from  to  and intermune inc from  to  mr bienaime received an mba from the wharton school at the university of pennsylvania and a degree in economics from the ecole superieure de commerce de paris source biomarin pharmaceutical inc on    sign up for equilar atlas and view jeanjacques bienaimes full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like jeanjacques bienaime more specifically youll be able to identify corporate executives in jeanjacques bienaimes network and community follow changes in jeanjacques bienaimes employment and moneyinmotion connect with jeanjacques bienaime through your network of conections view full profile   search for over  executive profiles bio example jeanjacques bienaime jeanjacques bienaimes connections  sign up now to view jeanjacques bienaimes  connections » jane e shaw former board member yahoo inc farah h champsi former board member kite pharma inc paul a friedman chairman president and chief executive officer madrigal pharmaceuticals inc henry j fuchs president worldwide research and development biomarin pharmaceutical inc james i healy former board member ascendis pharma as v bryan lawlis board member biomarin pharmaceutical inc norbert g riedel board member jazz pharmaceuticals public limited company herve hoppenot chairman of the board president and chief executive officer incyte corporation william d young chairman nanostring technologies inc alan j lewis former board member biomarin pharmaceutical inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla jan koum board member facebook inc philip l milstein board member the marcus corporation × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   biomarin pharmaceutical  email ceo bmrncom cfo login  day free trial biomarin pharmaceutical bmrncom  lindaro street san rafael ca  phone  fax  ticker bmrn type public employees    revenue  million   billion industry biotechhealthcarebiotechdrugs sic code   pharmaceutical preparations view employees it intelligence news currently hiring historical trends it intelligence show all accounting accounting software alumni management apparel management applicant tracking appointment scheduling architectural drafting assisted living association management attendance tracking auto dealer aviation maintenance budgeting bug tracking building maintenance business continuity business intelligence business management business process management catalog management church management claims processing classroom management clinical trial management cmms cms commercial loan computer security construction accounting construction management content management contract management cpu customer satisfaction data center management data entry data storage database management db systems debt collection digital asset management digital signage distribution donation management ehs management electronic discovery energy management environmental expense report field service management financial crm financial reporting financial risk management fleet management forms automation freight funeral home hardware healthcare management help desk hospitality property management human resource ide idea management insurance policy inventory control investigation management issue tracking it management it service js libraries knowledge management law enforcement law practice management lead management learning management system lease management legal case management library automation loan origination logistics manufacturing execution marketing automation medical billing medical lab medical practice management medical transcription membership management mental health mobile device management mortgage and loans network monitoring network security os other performance appraisal physical security point of sale procurement productivity professional services automation programming languages publishing and subscriptions purchasing quality management radiology real estate agency recruiting referral reservations risk management scheduling school accounting server software social media monitoring social networking software frameworks spc statistical analysis supply chain management task management telephony ticketing time tracking video editing vmware vmware no description available public relations public relations no description available project management software project management software no description available sign up to see all helpful hint the inside view displays a list of technologies and products used internally at a company f i r e w a l l show all analytics cdn cms ecommerce os site performance google analytics google analytics shows you the full customer picture across ads and videos websites and social tools tablets and smartphones that makes it easier to serve your current customers and win new ones google content related services personal publishing wordpress wordpress  popular blogging platform sign up to see all helpful hint the outside view displays all the technologies and devices which can be seen on the internet news and background news and background company in the news january    fundingfinancing amountundisclosedroundundisclosedlead investorbofa merrill lynchspending ongeneral corporate purposeslead investorjp morgan lead investormorgan stanleyspending onacquisition of prosensa holding nv read entire article sign up to see all press events background full company description is available with the free trial name email address department get data ed pervieux title ciovp free trial for email technology export robert baffi title executive vice president technical operations free trial for email operations export dan spiegelman title executive vice president chief financial officer free trial for email executive export philip scalzo title svpchief compliance officer free trial for email finance export jeff ajer title executive vice president chief commercial officer free trial for email executive export jeanjacques bienaime title chairmanceo free trial for email executive export miguel carrillo title vp financial planning  analysis no email avail executive export holly weng title executive medical director free trial for email executive export daniel grant title senior director enterprise architecture free trial for email executive export david shiao title director it security  compliance free trial for email executive export elizabeth moyle title senior director free trial for email executive export gary leong title associate director it application support and computer systems validation free trial for email executive export nicole miller title senior director global scientific affairs free trial for email executive export peter ehlen title associate director enterprise strategic platforms free trial for email executive export paul lauer title senior director engineering services free trial for email executive export pauline lee title director development sciences project management free trial for email executive export sarah clark title associate director global compliance  ethics free trial for email executive export scott corbin title sr director commercial systems  marketing operations free trial for email executive export scott jordan title director contrac mfg free trial for email executive export thomas lester title director product development free trial for email executive export henry fuchs title president worldwide research  development free trial for email executive export michael lindsay title sr automation engineer free trial for email technology export sean mccannell title sr talent advisor free trial for email executive export adrienne kolb title associate i free trial for email other export marcus curry title sr ra no email avail other export chris jones title mps sales specialist gulf coast region free trial for email other export charles oneill title vice president pharmacological sciences biomarin pharmaceutical inc free trial for email other export john henstrand title principal scientist free trial for email medical  science export james nickas title vice president pharmacovigilance medical writing development sciences quality free trial for email other export manisha deshmukh title regulatory affairs free trial for email other export pavan jhutti title regulatory affairs senior associate free trial for email executive export patrick pallansch title vp global medical affairs free trial for email other export virginia mui title principal assessment manager gcp compliance free trial for email executive export jennifer cosgrove title sr program manager free trial for email executive export joellen hunt title clinical project manager free trial for email executive export jen panganiban title qa manager free trial for email executive export lucy crockett title manager free trial for email executive export mona lancaster title category manager free trial for email executive export nick clark title it manager  lab technologies free trial for email executive export stacey caplan title sr project manager global corporate compliance  ethics free trial for email executive export showing  to  of  entries free trial to view full entries level and organization level and organization historical trends historical trends yearly quarterly weekly quarterly poll question date created current result votes only for logged in user additional info the company profile also contains facebook info phone numbers linkedin accounts cfo contacts and biomarin pharmaceutical email format addresses with the domain of bmrncom biomarin pharmaceutical a biotechdrugs company has its main office in san rafael ca if you sign up for our free trial you will see our emailbmrncom addresses company background full company description is available with the free trial similar companies depomed inc depomed inc is a newark cabased company working within the biotechdrugs industry you can find depomed inc email format addresses here with the domain depomedcom if you sign up for our free trial you will see our emaildepomedcom addresses plexxikon inc plexxikon inc a company that works within the biotechdrugs industry their profile on lead presents significant contact information such as cfo contacts phone numbers linkedin data and plexxikon inc email addresses with the plexxikoncomdomain format they have their head office in berkeley ca if you sign up for our free trial you will see our emailplexxikoncom addresses quark pharmaceuticals inc quark pharmaceuticals inc a company that works within the biotechdrugs industry their profile on lead presents significant contact information such as cfo contacts phone numbers linkedin data and quark pharmaceuticals inc email addresses with the quarkpharmacomdomain format they have their head office in fremont ca if you sign up for our free trial you will see our emailquarkpharmacom addresses company directory  biomarin pharmaceutical access to this page has been denied please verify you are a human please click i am not a robot to continue access to this page has been denied because we believe you are using automation tools to browse the website this may happen as a result of the following javascript is disabled or blocked by an extension ad blockers for example your browser does not support cookies please make sure that javascript and cookies are enabled on your browser and that you are not blocking them from loading reference id fdabeeeacfdddfbbbd powered by perimeterx  inc access to this page has been denied please verify you are a human please click i am not a robot to continue access to this page has been denied because we believe you are using automation tools to browse the website this may happen as a result of the following javascript is disabled or blocked by an extension ad blockers for example your browser does not support cookies please make sure that javascript and cookies are enabled on your browser and that you are not blocking them from loading reference id fdeeeeddf powered by perimeterx  inc access to this page has been denied please verify you are a human please click i am not a robot to continue access to this page has been denied because we believe you are using automation tools to browse the website this may happen as a result of the following javascript is disabled or blocked by an extension ad blockers for example your browser does not support cookies please make sure that javascript and cookies are enabled on your browser and that you are not blocking them from loading reference id feaceeeaafcda powered by perimeterx  inc bienaime jeanjacques  hillsborough  ca  company information products resources my account talk to a db advisor  business directory ca hillsborough business services nec business services at noncommercial site bienaime jeanjacques b bienaime jeanjacques claim this business  skyfarm dr hillsborough ca  get directions   business info founded  incorporated annual revenue  employee count  industries business services at noncommercial site contacts jeanjacques bienaime contact business your email address subject message send message company summary since  the company has been providing business services at noncommercial site verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   b view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved jeanjacques bienaime  biomarin pharmaceutical inc  zoominfocom portola pharmaceuticals appoints jeanjacques bienaime to board of directors skip to main content home topicsanimal studies biotechnology cancer cardiovascular cell biology environment genetics genomicsproteomics human studies infectious diseases metabolic diseases neuroscience pharma news technology watchscience connect eventslaboratory design conference rd  conference search socialfacebook linkedin twitter guidescompanies products learn login register subscribe channelsle aln ce for advertisement advertisement portola pharmaceuticals appoints jeanjacques bienaime to board of directors thu   am comments by the associated press portola pharmaceuticals inc today announced the appointment of jeanjacques bienaime to the companys board of directors mr bienaime currently serves as chief executive officer of biomarin pharmaceutical inc he is chairman of the board of neurogesx inc a member of the board of bio and a member of the advisory board of bellevue asset managements bioventures ii fundjeanjacques bienaime is a biotechnology and pharmaceutical industry veteran with more than  years of experience said william lis chief executive officer of portola his experience as a ceo managing and building fully integrated biotechnology companies and his expertise commercializing antithrombotic products will be invaluable to portola as we advance our two lead partnered product candidates elinogrel and betrixaban and our pipeline of proprietary products in cardiovascular disease and inflammation through clinical development and into commercializationmr bienaime joined biomarin which develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions in may  as chief executive officer and member of the board of directors prior to joining biomarin he served as chairman chief executive officer and president of genencor a biotechnology company focused on industrial bioproducts and targeted cancer biotherapeutics before that he served as chairman chief executive officer and president of sangstat medical corporation an immunologyfocused biotechnology company that he guided to profitability prior to its acquisition by genzyme corporation earlier in his career mr bienaime held several senior management positions at rhonepoulenc rorer pharmaceuticals now sanofiaventis culminating in the position of senior vice president of worldwide marketing and business development responsible for among other things the launch of lovenox for the prevention of pulmonary embolism and treatment of unstable angina in the united states he also worked at genentech inc where he was involved in the launch of tissue plasminogen activator tpa for the treatment of heart attackshe received an mba from the wharton school at the university of pennsylvania and an undergraduate degree in economics from the ecole superieure de commerce de parisabout portola pharmaceuticals incportola pharmaceuticals develops innovative therapeutics based on targets with established proofs of concept that are designed to provide significant advances over current treatments for cardiovascular disease and inflammation the company has global development and commercialization agreements with two of the worlds leading pharmaceutical companies collectively valued at about  billion in upfront and milestone payments plus doubledigit royalties on future sales betrixaban its oral direct factor xa inhibitor is licensed to merck  co inc and elinogrel its competitive reversible py adp receptor antagonist is licensed to novartis pharma ag both are phase  product candidates that have features to address the global multibillion dollar hospital specialty and chronic care anticoagulant and antiplatelet markets respectivelyportolas proprietary pipeline programs are focused on the discovery and development of prt a thromboxane receptor antagonist which is targeted to address a significant unmet need as a potential aspirin alternative for patients intolerant to aspirin prt a factor xa inhibitor antidote to help manage or reverse the bleeding complications in the tens of millions of patients expected to be treated with factor xa inhibitors or lowmolecular weight heparin worldwide in the next decade and prt a novel oral sykspecific kinase inhibitor to treat chronic inflammatory diseases including rheumatoid arthritis and certain cancers including nonhodgkins lymphoma and chronic lymphocytic leukemia for additional information visit wwwportolacom httpwwwportolacom  advertisement advertisement view the discussion thread connect with bioscience technology facebook linkedin twitter resources about us advertising info contact us contributor guidelines directory faqs privacy policy product announcement form subscriptions terms  conditions topics animal studies biotechnology cancer cardiovascular cell biology environment genetics genomicsproteomics human studies infectious diseases metabolic diseases neuroscience pharma news technology  copyright  advantage business media advertisement form  biomarin pharmaceutical for jun  filed by bienaime jean jacques research stocks news story skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  news  events  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print format change text size default text sizea larger text sizea largest text sizea form  biomarin pharmaceutical for jun  filed by bienaime jean jacques by k wizard—  pm et  httparchivefastedgarcomacrgczmlzhtzqovuicx filed on june   more bmrn news briefbiomarin pharmaceutical says european commission approves brineura as first treatment for cln disease reuters   am et  european commission approves brineura™ cerliponase alfa the first treatment for cln disease a form of batten disease and ultrarare brain disorder in children pr newswire   am et  biomarin to attend upcoming investor conference pr newswire   am et  copyright – fmr llc  all rights reserved  terms of use privacy security site map  stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top bofi log in for events hafc an earn epam sn log in for events chkp lho fit gts find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  am et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  bmrn stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventsbmrn biomarin pharmaceutical inc    as of pm et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade option chain price history download to csv file download to excel file log in for more news expand all collapse all biomarin to host second quarter  financial results conference call and webcast on wednesday august  at pm et pr newswire –  pm et  san rafael calif dialin number us  canada dialin number international dialin number conference id  replay dialin number replay international dialin number conference id  briefsarepta and biomarin report execution of global settlement reuters –  am et  sarepta therapeutics inc srpt  sarepta therapeutics srpt and biomarin pharmaceutical inc announce execution of a global settlement and a license agreement resolving exon skipping patent litigation sarepta therapeutics and biomarin pharmaceutical inc announce execution of a global settlement and a license agreement resolving exon skipping patent litigation globenewswire –  am et  sarepta therapeutics inc srpt a us commercialstage biopharmaceutical company focused on the discovery and development of unique rnatargeted therapeutics for the treatment of rare neuromuscular diseases and biomarin pharmaceutical inc bmrn a leading biotechnology company in therapies for rare genetic diseases announced today that sarepta and biomarin executed a license agreement that provides s briefbiomarin pharmaceutical says plans to initiate phase  registrational study in q  for bmn  reuters –  am et  biomarin pharmaceutical inc bmrn  biomarins investigational gene therapy for hemophilia a at e vgkg dose maintains average factor viii levels within normal range for over one year  biomarin pharmaceutical inc bmrn says plans to initiate a phase  registrational study in q  for bmn  source text for eikon further company coverage biomarins investigational gene therapy for hemophilia a at e vgkg dose maintains average factor viii levels within normal range for over one year pr newswire –  am et  san rafael calif briefbiomarin submits pegvaliase biologics license application to the us fda for treatment of phenylketonuria reuters –  am et  biomarin pharmaceutical inc bmrn  biomarin submits pegvaliase biologics license application to the us fda for treatment of phenylketonuria  biomarin pharmaceutical inc bmrn  ‍company also intends to submit an application for registration in european union by year end ​ source text for eikon further company coverage biomarin submits pegvaliase biologics license application bla to the us fda for treatment of phenylketonuria pku pr newswire –  am et  san rafael calif we believe that pegvaliase offers the promise of an important new treatment option for those adult patients with pku unable to manage their condition with existing treatments technical research on biotech equities  celsion sarepta therapeutics biomarin pharma and contravir pharma pr newswire –  am et  new york june   if you want a stock review on clsn srpt bmrn or ctrv then come over to httpdailystocktrackercomregister and sign up for your free customized report today httpdailystocktrackercomregister celsion  on thursday shares in lawrenceville new jersey headquartered celsion corp clsn recorded a trading volume of  million shares which was higher than their three  biomarin announces acceptance of late breaking abstract at the international society on thrombosis and haemostasis  congress pr newswire –  am et  san rafael calif we feel privileged to be presenting the only human data in gene therapy for hemophilia a at isth said hank fuchs md president worldwide research and development at biomarin isth is a global notforprofit membership organization advancing the understanding prevention diagnosis and treatment of thrombotic and bleeding disorders briefbiomarin pharmaceutical says european commission approves brineura as first treatment for cln disease reuters –  am et  biomarin pharmaceutical inc bmrn  european commission approves brineura the first treatment for cln disease a form of batten disease and ultrarare brain disorder in children  biomarin pharmaceutical inc bmrn says dosing administration includes all ages from birth source text for eikon further company coverage european commission approves brineura™ cerliponase alfa the first treatment for cln disease a form of batten disease and ultrarare brain disorder in children pr newswire –  am et  san rafael calif on april   the committee for medicinal products for human use the scientific committee of the european medicines agency adopted a positive opinion for the companys marketing authorization application for brineuratm following an accelerated review procedure reserved for medicinal products expected to be of major public health interest biomarin to attend upcoming investor conference pr newswire –  am et  san rafael calif about biomarin biomarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and lifethreatening rare disorders for additional information please visit wwwbiomarincom information on biomarins website is not incorporated by reference into this press release biotech stocks on investors radar  biomarin pharma eyegate pharma navidea biopharma and cellectar biosciences pr newswire –  am et  new york may   this morning stockcallerscom covers the performances of biomarin pharmaceutical inc bmrn eyegate pharmaceuticals inc eyeg navidea biopharmaceuticals inc navb and cellectar biosciences inc clrb according to a report on investors business daily spdr sp biotech rose more than  in the first three months of  httpstockcallerscomregistration briefbiomarin q gaap loss per share  reuters –  pm et  biomarin pharmaceutical inc bmrn  biomarin announces first quarter  financial results  q gaap loss per share   q earnings per share view   thomson reuters ibes  q revenue  million versus ibes view  million biomarin announces first quarter  financial results pr newswire –  pm et  san rafael calif financial highlights biomarin pharmaceutical inc bmrn today announced financial results for the first quarter ended march   for the quarter ended march   gaap net loss was  million or  per basic and diluted share compared to gaap net loss of  million or  per basic and diluted share for the quarter ended march   biomarin to attend two upcoming investor conferences pr newswire –  am et  san rafael calif about biomarin biomarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and lifethreatening rare disorders for additional information please visit wwwbiomarincom information on biomarins website is not incorporated by reference into this press release biomarin sets high price for rare pediatric brain disease drug reuters –  pm et  biomarin pharmaceuticals inc said the annual price for its drug which won us approval on thursday to treat a rare and fatal type of pediatric brain disease is expected to be  after mandatory government discounts and rebates briefbiomarin says brineura us annual price  reuters –  pm et  biomarin pharmaceutical inc bmrn  biomarin pharmaceuticals says expects to begin shipping just approved brineura within  weeks  biomarin says expected annual cost for brineura to be  for ultrarare pediatric brain disease  biomarin says will have copay program to assist with outofpocket cost of brineura source text for eikon further company coverage us fda approves biomarins batten disease drug reuters –  pm et  the united states food and drug administration said on thursday it had approved biomarin pharmaceutical incs bmrn drug to treat a type of batten disease a rare disorder that mainly affects the nervous system and is ultimately fatal the drug brineura is an enzyme replacement therapy designed to slow loss of walking ability in patients three years or older with cln disease fda approves brineura™ cerliponase alfa for the treatment of cln disease a form of batten disease and ultrarare pediatric brain disorder in children pr newswire –  pm et  san rafael calif cln disease is an ultrarare rapidly progressive fatal brain condition which affects less than one in one million us residents many of whom are undiagnosed in clinical trials brineura an enzyme replacement therapy was shown to slow the loss of ambulation in symptomatic pediatric patients  years of age and older with cln disease page page   next  todays and upcoming events aug  bmrn to announce q earnings after market confirmed aug  bmrn earnings conference call at  pm listen past events last  days jun  shareholders meeting data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft loading your search results  beenverifiedcom updating data on  live please help us narrow down your search all states alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming im not sure please enter a full name please help us narrow down your search first name please enter first name last name please enter last name people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again jacques bien aime  wowcom  web results aol search skip over navigation search the web web images images reference reference we found this person  cell phone  address pics  more ad · wwwspokeocom​searchfree cell phone  address pics  more get anyones info  look free free people search search public records white pages directory social network search web results jacques bien aime profiles  facebook httpswwwfacebookcompublicjacquesbienaime view the profiles of people named jacques bien aime join facebook to connect with jacques bien aime and others you may know facebook gives people the jacques bienaimé profiles  facebook httpswwwfacebookcompublicjacquesbienaimé jacques bienaime jacques bienaime see photos jacques bienaime see photos jacques bienaime see photos pierreandre andrew jacques bienaim  jacques bienaime   public records found httpswwwinstantcheckmatecompeoplejacquesbienaime jacques bienaime was found  times in our database matches found in  cities including north miami beach florida miami florida  north miami florida jean jacques bienaime  linkedin httpswwwlinkedincominjeanjacquesbienaimea view jean jacques bienaime’s professional profile on linkedin linkedin is the worlds largest business network helping professionals like jean jacques bienaime  jacques bienaimes phone number email address  spokeo httpswwwspokeocomjacquesbienaime  records for jacques bienaime find jacques bienaimes phone address and email on spokeo the leading online directory jacques bienaime b   somerville ma  mylifecom  httpswwwmylifecomjacquesbienaimejacquesbienien jacques bienaime was born in  jacques currently lives in somerville  before that he  jacques bienaime jakbienaime  twitter httpstwittercomjakbienaime the latest tweets from jacques bienaime jakbienaime hasta siempre comandante  fidel tu as marqué ma jeunesse pour un peuple faire face au destin passe par  jacques bienaime  people search  whitepages wwwwhitepagescomnamejacquesbienaime  results for jacques bienaime find contact information for over  of all us adults phone numbers addresses public records and more are available from  jeanjacques bienaime  biomarin wwwbiomarincomaboutleadershipteamjeanjacquesbienaime jeanjacques bienaime chairman and chief executive officer mr bienaimé is currently the chairman and chief executive officer at biomarin he joined the company in  jacques bien aime   bloomfield nj  mylifecom  httpswwwmylifecomjacquesbienaimee view free background profile for jacques bien aime on mylifecom™  phone    b st address bloomfield nj   emails  photos   profiles   review  more we found this person  cell phone  address pics  more ad · wwwspokeocom​searchfree cell phone  address pics  more get anyones info  look free free people search search public records white pages directory social network search next answers sonia bienaime sonia bienaime born  december  is a turks and caicos football administrator the president of the turks and caicos islands football association more louisjacques boucot panthère babylas explorateur babylas habite une maison bien tranquille and madame babylas aime les animaux in   babylas va se marier in  more jacques telesphore roman family had reached their pinnacle jacques brother andre was serving his first term as governor of louisiana and his sister josephine was married to more search the web  aol inc all rights reservedprivacy   terms of use   about our ads   preferences   contact us   powered by bing™ part of the aol search network